Created with Highcharts 11.1.0Jul '24Oct '24Jan '25Apr '25200.00257.01

Profile

Edit
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.
URL https://www.insulet.com
Investor Relations URL https://investor.insulet.com
HQ State/Province Massachusetts
Sector Health Care
Industry Health Care Equipment & Supplies
Next Earnings Release May. 08, 2025
Last Earnings Release Feb. 20, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Edit
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.
URL https://www.insulet.com
Investor Relations URL https://investor.insulet.com
HQ State/Province Massachusetts
Sector Health Care
Industry Health Care Equipment & Supplies
Next Earnings Release May. 08, 2025
Last Earnings Release Feb. 20, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A
Quickflows